Search clinical trials for: Opioid Rapid Resonse System (ORRS) training

Total 94 results

University of Missouri-Columbia

Not yet recruiting

Opioid Rapid Response System: Naloxone Training in Communities

Opioid Overdose
University of Kent
Kent Community Health NHS Foundation Trust; NHS Kent and Medway

Recruiting

DE-eSCALation of Opioids Post-surgical dischargE (DESCALE)

Opioid Dependence

United Kingdom
Medical Research Council, South Africa
University of Ghana

Unknown

Impact Assessment of the Rural Response System to Reduce Violence Against Women in Ghana (GhanaCHiPS)

Sexual Violence | Domestic Violence | Physical Violence

Ghana
Brown University

Completed

Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs (RAPiDS2)

Accidental Overdose of Opiate

United States
Vanderbilt University Medical Center

Completed

Validation of the NTX Wireless Patient Monitoring System (TATRC)

Hypertension | Bradycardia | Tachycardia | Hypotension | Desaturation

United States
University of California, San Diego

Completed

Research in Autism: Parent Intervention

Autistic Disorder

United States
National Development and Research Institutes, Inc.

Unknown

Mobile Intervention for Young Opioid Users

Opioid-Related Disorders

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of California, Los Angeles

Enrolling by invitation

Technology for MAT in Primary Care - Phase 2

Opioid-use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of California, Los Angeles

Completed

Technology for MAT in Primary Care - Phase 1

Opioid-use Disorder

United States
New York University
Centers for Disease Control and Prevention

Active, not recruiting

Opioids and Police Safety Study (OPS)

Opioid Overdose

United States
Alza Corporation, DE, USA

Completed

An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg

Analgesia
Shanghai Zhongshan Hospital

Recruiting

OFA in Thoracic Surgery

Thoracic Cancer

China
Mallinckrodt

Completed

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

Chronic Pain
Janssen Korea, Ltd., Korea

Completed

Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid

Pain

Korea, Republic of
Alza Corporation, DE, USA

Completed

A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain

Pain | Analgesics | Opioid
Janssen Korea, Ltd., Korea

Completed

An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

Pain
Janssen Korea, Ltd., Korea

Completed

Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients

Cancer Pain

Korea, Republic of
Alza Corporation, DE, USA

Completed

A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain

Pain | Analgesics, Opioid
Mallinckrodt

Completed

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

Chronic Low Back Pain
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer

Pain | Cancer
Alza Corporation, DE, USA

Completed

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

Pain | Analgesics, Opioid
Alza Corporation, DE, USA

Completed

A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain

Pain, Postoperative | Analgesia | Orthopedic Procedures
Janssen-Cilag International NV

Completed

Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee

Pain | Osteoarthritis, Knee | Osteoarthritis, Hip

United Kingdom, Romania, Slovakia, Czech Republic
Lebanese American University

Completed

Opioid Free Anesthesia and Major Spine Surgery

Postoperative Pain | Opioid Use | Spine Disease

Lebanon
University of Toronto
University of Rwanda; ANZCA Health Equity Project

Completed

Can VAST Improve ACLS in Rwanda

Education | Resuscitation | Global Health

Rwanda
Alza Corporation, DE, USA

Completed

A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain

Pain | Analgesics, Opioid
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.

Pain

France, Poland, Germany, Slovenia, Sweden, Czech Republic, Norway, Slovakia, Switzerland, Denmark
Alza Corporation, DE, USA

Completed

A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis

Osteoarthritis, Knee | Osteoarthritis, Hip
Alza Corporation, DE, USA

Completed

Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain

Pain | Analgesics, Opioid
Peking University People's Hospital

Completed

Opioid Free Anesthesia in Breast Cancer Surgery

Opioid Free Anesthesia

China
Janssen Pharmaceutica

Terminated

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Pain
AZ Sint-Jan AV

Completed

Impact of Opioid Free Anesthesia on Outcome After DIEPflap Surgery (DIEPflap)

Major and Minor Surgical Complications

Belgium
Alza Corporation, DE, USA

Completed

A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.

Pain | Analgesics, Opioid
Alza Corporation, DE, USA

Completed

Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain

Pain
Alza Corporation, DE, USA

Completed

An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)

Osteoarthritis, Knee | Osteoarthritis, Hip
Alza Corporation, DE, USA

Completed

Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain

Low Back Pain
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care

Heart Failure, Congestive

United States
University of California, San Francisco

Recruiting

Opioid Approach Bias Modification (OABM)

Chronic Pain | Opioid Use

United States
Heart Institute, Ministry of Health of Ukraine

Active, not recruiting

Anesthesia Standard Operating Procedure During On-pump Coronary Artery Bypass Grafting

Coronary Artery Disease | Postoperative Complications | Atrial Fibrillation | Low Cardiac Output Syndrome

Ukraine
Johnson & Johnson Taiwan Ltd

Terminated

A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain

Cancer Pain
University of South Florida

Recruiting

Opioid Free Anesthesia vs. Opioid Anesthesia Techniques. (OFA vs OA)

Colectomy | Analgesic Drug Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

The Effect of Cognitive Enhancement as a Precursor to Computer Based Training for Cognitive Behavioral Therapy (CBT4CBT) (Project 1)

Cocaine Use Disorder

United States
Boston Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Linking Infectious and Narcology Care-Part II (LINC-II)

HIV Infection | Drug Use

Russian Federation
Dennis Jensen, Ph.D.

Unknown

Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness (MorEx)

Chronic Obstructive Pulmonary Disease | Interstitial Lung Disease

Canada
Alza Corporation, DE, USA

Completed

A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain

Low Back Pain
Copenhagen University Hospital at Herlev

Unknown

Local Anaesthesia and Remifentanil Sedation Versus Total Intravenous Anaesthesia for Hysteroscopic Surgery in an Ambulatory Surgery Department.

Conscious Sedation | Remifentanil | Anesthesia Recovery Period | Ambulatory Surgery | Hysteroscopic Surgery

Denmark
Dr. Soliman Fakeeh Hospital

Completed

Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section

Itching
Gaylord Hospital, Inc

Completed

Explorations of the Benefits of the ZeroG TRiP System to Improve Balance in Patients Following Stroke

Stroke | Balance; Distorted

United States
Medical University of South Carolina

Completed

A Pilot Trial to Determine the Effective N-acetylcysteine Dose for Opioid Reduction for Spine Surgery.

Surgery

United States
Shaare Zedek Medical Center

Completed

Use of Caudal Anesthesia Supplemented With Morphine in Children Undergoing Renal Surgery

Anesthesia, Caudal

Israel

3

Subscribe